ロード中...

Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma

BACKGROUND: Plasminogen activator inhibitor 1 (PAI-1) was previously established to impact several phenotypes in many kinds of cancer, including pancreatic cancer. However, its prognostic significance in pancreatic ductal adenocarcinoma (PDAC) needs support of further evidence. This study was design...

詳細記述

保存先:
書誌詳細
出版年:Chin Med J (Engl)
主要な著者: Liu, Wen-Jing, Zhou, Li, Liang, Zhi-Yong, Zhou, Wei-Xun, You, Lei, Zhang, Tai-Ping, Zhao, Yu-Pei
フォーマット: Artigo
言語:Inglês
出版事項: Medknow Publications & Media Pvt Ltd 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6302640/
https://ncbi.nlm.nih.gov/pubmed/30539907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0366-6999.247211
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!